Pig kidney transplant recipient dies
Richard Slayman has passed away two months after undergoing the historic procedure
What happened
Richard "Rick" Slayman, the first patient to receive a genetically modified pig kidney, has died, his family and Boston's Massachusetts General Hospital said Sunday. Slayman, 62, underwent four hours of surgery at Mass General on March 16 and was released from the hospital in early April, no longer needing dialysis and with "one of the cleanest bills of health I've had in a long time," he said at the time.
Who said what
Mass General said it was "deeply saddened" at Slayman's "sudden passing" and has "no indication that it was the result of his recent transplant." The hospital's transplant team also thanked Slayman for his "trust and willingness to advance the field of xenotransplantation," or transplanting animal organs into humans.
What next?
Slayman's operation was a "medical milestone," showing that animal organs genetically modified to "make them more compatible with their recipients" can be successfully transplanted, at least for a short while, The New York Times said. Slayman's family said he accomplished his goal of providing "hope for the thousands of people who need a transplant to survive."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Will inflation surge again?
Talking Points The Federal Reserve is cautious about Trump's policies
By Joel Mathis, The Week US Published
-
What happens to wildlife during a wildfire?
The explainer Flames also affect the flora and fauna
By Devika Rao, The Week US Published
-
Biden awards Pope Francis highest US civilian honor
Speed Read President Joe Biden awarded Pope Francis the Presidential Medal of Freedom with Distinction
By Peter Weber, The Week US Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
The dark side of the contraceptive coil
Under the Radar Study linking hormonal IUD to increased breast cancer risk adds to growing concerns about whether the benefits of the coil outweigh the risks
By Harriet Marsden, The Week UK Published